These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 8103458)

  • 21. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G; LeDuc PA; Whishaw IQ
    Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholine receptor effects on accumbal shell dopamine-mediated turning behaviour in rats.
    Moribe S; Ikeda H; Sato M; Akiyama G; Matsuzaki S; Hasegawa K; Koshikawa N; Cools AR
    Neuropharmacology; 2005 Sep; 49(4):514-24. PubMed ID: 15935407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM; Boldry RC; Kuo S; Chase TN
    Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U; Löscher W
    Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-activation of D1- and D2-like receptors is unnecessary for stimulated motor behavior in rats depleted of dopamine during development.
    Byrnes EM; Abrams D; Bruno JP
    Behav Brain Res; 1994 Apr; 61(2):205-14. PubMed ID: 7913605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon.
    Singh J; Desiraju T; Raju TR
    Behav Brain Res; 1997 Jul; 86(2):171-9. PubMed ID: 9134152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABA(A) agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens.
    Kitamura M; Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2001; 104(1):117-27. PubMed ID: 11311536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral injections of a D2 but not D1 agonist into the frontal cortex of rats produce a contralateral directional bias.
    Beninger RJ; Musgrave MA; Dickson PR
    Pharmacol Biochem Behav; 1990 Nov; 37(3):387-92. PubMed ID: 1982354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY; Zhou LW; Friedman E; Weiss B
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of orexin receptors in the nucleus accumbens in dopamine-dependent turning behaviour of rats.
    Kotani A; Ikeda H; Koshikawa N; Cools AR
    Neuropharmacology; 2008 Mar; 54(3):613-9. PubMed ID: 18160080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.